1 terminated, 1 withdrawn. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Terminated 1, Withdrawn 1 |
Follow Mezlocillin: new trials by email Literature Review of Mezlocillin trials Research Report on Mezlocillin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mood and Cognitive Effects of Psilocybin in Healthy Participants Psilocybin, Inonotus Obliquus Whole Extract - Mood Disturbance, Mood Change | Early Phase 1 | Withdrawn | Optimi Health Corporation | 2023-01-01 | 2023-03-20 | |
| Patients Response to Early Switch To Oral:Osteomyelitis Study oral antibiotics, intravenous antibiotics - Osteomyelitis | Early Phase 1 | Terminated | Julio Ramirez | 11 | 2014-03-06 | 2021-04-06 |
Anxiety Disorders (1) · Osteomyelitis (1) · Parasomnias (1)
Julio Ramirez (1) · Optimi Health Corporation (1)
United States (1)
David Seligson, MD (1) · Julio Ramirez, MD (1) · Valerie Taylor, MD/PhD (1)
PMID 15276398, PMID 15840453, PMID 19588358, PMID 22530208, PMID 4902833, PMID 8948280